Raj K. Maturi, MD
Show Description +
Raj K. Maturi, MD, reviews the key points of a short-term study on the effect of adding dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan) to continued ranibizumab (Lucentis, Genentech) treatment in patients with persistent diabetic macular edema (DME).
Posted: 7/21/2018
Raj K. Maturi, MD
Raj K. Maturi, MD, reviews the key points of a short-term study on the effect of adding dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan) to continued ranibizumab (Lucentis, Genentech) treatment in patients with persistent diabetic macular edema (DME).
Posted: 7/21/2018
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2018.
Please log in to leave a comment.